全球记忆障碍市场 – 行业趋势和 2029 年预测

记忆障碍市场分析与洞察

预计市场在预测期内将经历巨大增长，因为记忆相关疾病的患病率将会增加，这种疾病通常会影响全球数百万人，尽管在老年人中更为常见。此外，由于 COVID-19 突然爆发造成的限制影响，预计市场在预测期内将出现负增长。

• Data Bridge Market Research 分析，在 2022 年至 2029 年的预测期内，记忆障碍市场将以 7.90% 的复合年增长率增长。在预测期内，“痴呆症”占记忆障碍市场中最大的类型细分市场。

记忆障碍市场定义

记忆障碍是一种由于记忆存储、检索和保留困难而导致大脑神经解剖结构受损的疾病。根据疾病类型，记忆障碍可分为轻度、中度或重度。

记忆障碍市场动态

驱动程序

• 记忆障碍病例不断增加

神经系统和记忆相关疾病患病率的上升将导致治疗市场的增长率扩大。

此外，不健康的生活方式和压力大的环境也会增加罹患精神疾病的风险，这也是推动市场增长的决定因素。此外，治疗的可用性将进一步促进记忆障碍市场的增长。

此外，不断增加的宣传活动，使人们认识到与记忆有关的疾病，以及认知药物带来的益处（如改善记忆和推理能力），都是扩大记忆障碍市场的因素。具有成本效益的药物可以视为积极影响记忆障碍市场增长率的进步因素之一。

机会

此外，新技术和创新药物的引入将为市场增长率带来新的机会。此外，政府资金和宣传计划的增加以及医疗技术的发展将在未来提高记忆障碍市场的增长率。

全球记忆障碍市场的限制/挑战

However, due to the wideness of memory disorder class and ethical issues related to the use of its drugs will impede the growth rate of memory disorders market. Additionally, the stringent FDA guideline for the approval for the treatment is projected to hamper the growth of the market growth.

This memory disorders market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on memory disorders market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

The memory disorders are basically the mental illnesses that affect one's ability to think, remember, make decisions, and communicate. According to research, there were over 850,000 dementia patients in the UK in 2019. At the current rate of prevalence, there will be over 1.5 million people in the UK with dementia by 2040.

Memory disorders market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Memory Disorders Market

Healthcare and pharmaceutical industries were heavily impacted by the COVID-19. The memory disorders market was however affected negatively by the sudden emergence of the COVID-19 which caused restrictive containment measures such as social distancing, remote working, and the closure of industries and other commercial activities, all of which have created operational challenges. The implementation of strict lockdowns and isolation regulations across the globe further complicated the disease management and medication adherence and even further caused delays in the import and export of drugs and medicines for the memory disorders as the entire supply chain has been disrupted, which has had a negative impact on the market. Moreover, the COVID-19 pandemic is expected to harm the new product launches, thus further hampering the overall growth opportunities for the market.

Recent Developments

• In Oct 2020, Third Dementia Innovation Readiness Index was launched in 30 global cities by Alzheimer's disease International, the Global Coalition on Aging (GCOA), and the Lien Foundation.
• In Jan 2021, The LSP Dementia Fund, a fund dedicated to fighting neurodegenerative diseases, was launched in Amsterdam by LSP, Europe's leading life sciences investor, and Professor Philip Scheltens, a world-renowned dementia scientist.

Global Memory Disorders Market Scope

The memory disorders market is segmented on the basis of type, medication, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Dementia
• Amnesia
• Others

On the basis of type, memory disorders market is segmented into dementia, amnesia and others. Dementia is further divided into dementia with lewy bodies, frontotemporal dementia, HIV dementia, vascular dementia, Alzheimer's disease, mild cognitive impairment, normal pressure hydrocephalus and others. Amnesia is further divided into transient global amnesia, Korsakoff syndrome and others. Dementia is expected to show significant growth due to the high prevalence of this disorder across the globe.

Medication

• Drugs
• Physical Therapy
• Psychotherapy
• Others

On the basis of medication, memory disorders market is segmented into drugs, physical therapy, psychotherapy and others.

Route of Administration

• Oral
• Parenteral
• Others

On the basis of route of administration, the memory disorders market is segmented into oral, parenteral and others.

End-Users

• Hospitals
• Specialty Clinics
• Others

On the basis of end-users, the memory disorders market is segmented into hospitals, specialty clinics and others.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Others

On the basis of distribution channel, the memory disorders market is segmented into hospital pharmacy, retail pharmacy and others.

Memory Disorders Market Regional Analysis/Insights

The memory disorders market is analyzed and market size insights and trends are provided by country, type, medication, route of administration, end-users and distribution channel as referenced above.

The countries covered in the memory disorders market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

北美在市场份额和市场收入方面占据记忆障碍市场的主导地位，并将在预测期内继续保持主导地位。这是因为记忆障碍的负担增加、高研发和医疗保健支出以及市场上药物的可用性可能会增加该地区记忆障碍治疗市场。

另一方面，由于亚太地区经济价值的增加、技术的进步以及治疗药物的需求不断增加，预计预测期内亚太地区将呈现最高的增长率。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。

竞争格局和记忆障碍市场份额分析

记忆障碍市场竞争格局提供了按竞争对手划分的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对记忆障碍市场的关注有关。

记忆障碍市场的一些主要参与者包括诺华公司、阿斯利康、百时美施贵宝公司、艾伯维公司、礼来公司、辉瑞公司、VTV Therapeutics、H. Lundbeck A/S、TauRx Pharmaceuticals Ltd、第一三共有限公司、葛兰素史克公司、默克公司、Echo Pharma、Teva Pharmaceuticals Industries Ltd.、武田制药有限公司、拜耳公司、Biogen、WOCKHARDT BIO AG.、Dr. Reddy's Laboratories Ltd.、太阳制药工业有限公司、艾尔建和迈兰公司等。

SKU-52523